Inventor · disambiguated record
Andrea Vaupel
Also filed as: VAUPEL ANDREA · VAUPEL ANDREA HELGA EMMI
31 granted patents·19 pending applications·420 citations·filing 1999–2022
97Inventor score
Top patents by PatentIndex Score
50 records- 0197US8026247B2Bicyclic amides as kinase inhibitorsNOVARTIS AG·Filed 2005·Granted Sep 27, 2011·60 cites·3 claims
- 0292US7078417B2Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparationsBAYER AG·Filed 2002·Granted Jul 18, 2006·59 cites·8 claims
- 0392US6677360B2Biphenyl and biphenyl-analogous compounds as integrin antagonistsBAYER AG·Filed 2001·Granted Jan 13, 2004·29 cites·26 claims
- 0492US6420396B1Biphenyl and biphenyl-analogous compounds as integrin antagonistsBAYER AG·Filed 1999·Granted Jul 16, 2002·59 cites·12 claims
- 0591US7129255B2Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptorBAYER AG·Filed 2002·Granted Oct 31, 2006·55 cites·6 claims
- 0690US8969341B2Pyrazolopyrrolidine compoundsFURET PASCAL·Filed 2012·Granted Mar 3, 2015·8 cites·13 claims
- 0788US7135486B1Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereofBAYER AG·Filed 2000·Granted Nov 14, 2006·35 cites·17 claims
- 0886US7855219B2Substituted 2-oxy-3,5-dicyano-4aryl-6-aminopyridines and use thereofBAYER SCHERING PHARMA AG·Filed 2002·Granted Dec 21, 2010·26 cites·5 claims
- 0986US7855215B2Cyclic diaryl ureas suitable as tyrosine kinase inhibitorsNOVARTIS AG·Filed 2005·Granted Dec 21, 2010·6 cites·19 claims
- 1085US8815926B2Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseasesNOVARTIS AG·Filed 2013·Granted Aug 26, 2014·8 cites·25 claims
- 1183US8242281B2Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligandsROSENTRETER ULRICH·Filed 2006·Granted Aug 14, 2012·6 cites·5 claims
- 1282US7825255B2Adenosine receptor selective modulatorsBAYER SCHERING PHARMA AG·Filed 2002·Granted Nov 2, 2010·18 cites·5 claims
- 1382US7652022B2Diaryl urea derivatives useful for the treatment of protein kinase dependent diseasesNOVARTIS AG·Filed 2003·Granted Jan 26, 2010·21 cites·9 claims
- 1478US7504421B2Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their useROSENTRETER ULRICH·Filed 2006·Granted Mar 17, 2009·4 cites·13 claims
- 1577US8975417B2Pyrazolopyrrolidine derivatives and their use in the treatment of diseaseBORDAS VINCENT·Filed 2014·Granted Mar 10, 2015·6 cites·24 claims
- 1677US8030311B2Phenylacetamides suitable as protein kinase inhibitorsNOVARTIS AG·Filed 2006·Granted Oct 4, 2011·2 cites·10 claims
- 1773US8053457B23-imidazolyl-indoles for the treatment of proliferative diseasesNOVARTIS AG·Filed 2008·Granted Nov 8, 2011·3 cites·11 claims
- 1872US8748435B2Pyrazolo pyrimidine derivativesMILTZ WOLFGANG·Filed 2012·Granted Jun 10, 2014·5 cites·12 claims
- 1972US7625894B2Pyrrolo[2,3-d]Pyrimidines as Protein Tyrosine Kinase InhibitorsNOVARTIS AG·Filed 2005·Granted Dec 1, 2009·1 cites·5 claims
- 2069US9556180B2Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interactionNOVARTIS AG·Filed 2014·Granted Jan 31, 2017·1 cites·11 claims
- 2168US9403827B2Substituted purinone compoundsFURET PASCAL·Filed 2014·Granted Aug 2, 2016·1 cites·10 claims
- 2268US7795288B2Thiazole and pyrazole derivatives as Flt-3 kinase inhibitorsNOVARTIS AG·Filed 2004·Granted Sep 14, 2010·3 cites·6 claims
- 2366US9365576B2Pyrrolopyrrolidinone compoundsCOTESTA SIMONA·Filed 2013·Granted Jun 14, 2016·2 cites·12 claims
- 2463US6545029B2Phenylserine derivatives as integrin antagonistsBAYER AG·Filed 2001·Granted Apr 8, 2003·2 cites·7 claims
- 2559US2024317721A1Pyrazolyl derivatives as inhibitors of the kras mutant proteinNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2656US2024366567A1Pharmaceutical combinations comprising a kras g12c inhibitor and uses thereof for the treatment of cancersNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2754US2013040992A1Substituted 2, 6-Diamino-3, 5-Dicyano-4-Aryl-Pyridines And Their Use As Adenosine-Receptor-Selective LigandsBAYER IP GMBH·Filed 2012·Application pending·0 cites
- 2853US8133886B2Heterobicyclic carboxamides as inhibitors for kinasesBOLD GUIDO·Filed 2007·Granted Mar 13, 2012·0 cites·12 claims
- 2953US2024082218A1Pharmaceutical combinations comprising a kras g12c inhibitor and uses of a kras g12c inhibitor for the treatment of cancersNOVARTIS AG·Filed 2021·Application pending·0 cites
- 3052US12226405B2Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of useNOVARTIS AG·Filed 2021·Granted Feb 18, 2025·0 cites·30 claims
- 3152US2014343084A1Imidazopyrrolidinone compoundsNOVARTIS AG·Filed 2014·Application pending·0 cites
- 3251US2024116900A1New crystalline forms of a kras g12c inhibitor compoundNOVARTIS AG·Filed 2021·Application pending·0 cites
- 3350US11702409B2Pyrazolyl derivatives useful as anti-cancer agentsNOVARTIS AG·Filed 2020·Granted Jul 18, 2023·0 cites·34 claims
- 3450US2004162427A1Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligandsFiled 2002·Application pending·0 cites
- 3548US7094911B2Biphenyl and biphenyl-analogous compounds as integrin antagonistsBAYER AG·Filed 2002·Granted Aug 22, 2006·0 cites·23 claims
- 3647US8058276B2Heterobicyclic carboxamides as inhibitors for kinasesBOLD GUIDO·Filed 2007·Granted Nov 15, 2011·0 cites·5 claims
- 3746US9890166B2Imidazopyrrolidine derivatives and their use in the treatment of diseaseBLANK JUTTA·Filed 2014·Granted Feb 13, 2018·0 cites·13 claims
- 3846US2009118277A13 Unsubstituted N-(aryl- or heteroaryl)-pyrazolo[1,5-a]pyrimidines as Kinase InhibitorsNOVARTIS AG·Filed 2007·Application pending·0 cites
- 3946US2016095843A1Pyrazolopyrrolidine derivatives and their use in the treatment of diseaseBLANK JUTTA·Filed 2014·Application pending·0 cites
- 4045US2012122857A1Heterobicyclic carboxamides as inhibitors for kinasesBOLD GUIDO·Filed 2012·Application pending·0 cites
- 4145US2012184561A1Phenylacetamides suitable as protein kinase inhibitorsBOLD GUIDO·Filed 2011·Application pending·0 cites
- 4245US2009131437A1Disubstituted ureas as kinase inhibitorsCORIUM INT INC·Filed 2006·Application pending·0 cites
- 4344US2008312192A1Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent DiseasesBOLD GUIDO·Filed 2004·Application pending·0 cites
- 4443US2011301157A1Bicyclic amides as kinase inhibitorsBOLD GUIDO·Filed 2011·Application pending·0 cites
- 4541US2005154061A1Acetic acid derivativesBAYER AG·Filed 2002·Application pending·0 cites
- 4639US9550796B2Pyrrolopyrrolone derivatives and their use as BET inhibitorsRUEGER HEINRICH·Filed 2014·Granted Jan 24, 2017·0 cites·13 claims
- 4737US2012289501A1Benzene-fused 6-membered oxygen-containing heterocyclic derivatives of bicyclic heteroarylsCHEN BEI·Filed 2010·Application pending·0 cites
- 4836US2012165310A1Ether derivatives of bicyclic heteroarylsCHEN BEI·Filed 2010·Application pending·0 cites
- 4934US2005234096A1Tetrahydroisoquinoline derivativesBISCHOFF HILMAR·Filed 2003·Application pending·0 cites
- 5033US2012149661A1Tetra-substituted heteroaryl compounds and their use as mdm2 and/or mdm4 modulatorsBOLD GUIDO·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrea Vaupel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →